Lorcaserin Extended-Release Tablets and Omadacycline Tosylate
Determining the interaction of Lorcaserin Extended-Release Tablets and Omadacycline Tosylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: omadacycline
Brand name: Nuzyra
Synonyms: Omadacycline (oral/injection), Omadacycline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Omalizumab
- Lorcaserin Extended-Release Tablets-Omalizumab Subcutaneous
- Lorcaserin Extended-Release Tablets-Ombitasvir, Paritaprevir, and Ritonavir
- Lorcaserin Extended-Release Tablets-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Lorcaserin Extended-Release Tablets-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Lorcaserin Extended-Release Tablets-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Omadacycline Tosylate-Lorcaserin Hydrochloride
- Omadacycline Tosylate-Lorcaserin Tablets
- Omadacycline Tosylate-Lorcet
- Omadacycline Tosylate-Lorcet Plus
- Omadacycline Tosylate-Lorcet Tablets
- Omadacycline Tosylate-Lorlatinib